Pediatric Nephrology

, Volume 29, Issue 4, pp 711–719

Renal progenitors and childhood: from development to disorders

  • Francesca Becherucci
  • Elena Lazzeri
  • Laura Lasagni
  • Paola Romagnani
Review

DOI: 10.1007/s00467-013-2686-2

Cite this article as:
Becherucci, F., Lazzeri, E., Lasagni, L. et al. Pediatr Nephrol (2014) 29: 711. doi:10.1007/s00467-013-2686-2

Abstract

Nephropathies arise from conditions that alter nephron development or trigger nephron damage during neonatal, juvenile, and adult stages of life. Much evidence suggests that a key role in maintaining kidney integrity, homeostasis, and regenerative capacity is played by a population of progenitor cells resident in the organ. Although the primary goals in the field of renal progenitor cells are understanding their ability to regenerate nephrons and to restore damaged kidney function, the discovery of these cells could also be used to elucidate the molecular and pathophysiological basis of kidney diseases. As a result, once the identification of a subset of progenitor cells capable of kidney regeneration has been obtained, the increasing knowledge about their characteristics and about the mechanisms of renal development had pointed out the possibility of understanding the molecular basis of kidney diseases, so that, nowadays, some renal disorders could also be related to renal progenitor dysfunction. In this review, we summarize the evidence on the existence of renal progenitors in fetal and adult kidneys and discuss their role in physiology as well as in the pathogenesis of renal disorders with a particular focus on childhood age.

Keywords

Renal progenitorsKidney regenerationRenal hypoplasiaFocal segmental glomerulosclerosis

Copyright information

© IPNA 2014

Authors and Affiliations

  • Francesca Becherucci
    • 1
    • 2
  • Elena Lazzeri
    • 2
  • Laura Lasagni
    • 2
  • Paola Romagnani
    • 1
    • 2
    • 3
  1. 1.Pediatric Nephrology and Dialysis UnitMeyer Children’s University HospitalFlorenceItaly
  2. 2.Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE)University of FlorenceFlorenceItaly
  3. 3.Department of Clinical and Experimental Biomedical SciencesUniversity of FlorenceFlorenceItaly